Statin-related myopathies
- 1 March 2018
- journal article
- review article
- Published by BMJ in Practical Neurology
- Vol. 18 (2), 97-105
- https://doi.org/10.1136/practneurol-2017-001738
Abstract
Statins are the Marmite (‘You either love it or hate it!’) of the drug world, both in terms of therapeutic benefit and risk of side effects. Proponents think that they are potential life-savers, opponents that their main benefit is lining the pockets of pharma. Some consider side effects to be a major issue, outweighing any therapeutic benefit, others that they are rare and essentially innocuous. Statin-induced myalgia is relatively common but often mild and for most people does not limit treatment. In others, reducing the dose or changing the preparation may help. In all, withdrawal of the statin leads to resolution. Statin-induced rhabdomyolysis, most often precipitated by drug–drug interaction, affects only a tiny proportion of statin users, but because of the widespread prescribing of statins is an important clinical problem. Statin-induced immune-mediated necrotising myopathy represents a novel disease mechanism and clinically mimics forms of myositis. Resolution often requires immunosuppressant drug treatment, as well as statin withdrawal.Keywords
This publication has 35 references indexed in Scilit:
- Statins and the neuromuscular system: a neurologist's perspectiveEuropean Journal of Neurology, 2014
- A systematic review of statin-induced muscle problems in clinical trialsAmerican Heart Journal, 2014
- Low Vitamin D as a Risk Factor for the Development of Myalgia in Patients Taking High-Dose Simvastatin: A Retrospective ReviewClinical Therapeutics, 2014
- Effect of Statins on Skeletal Muscle FunctionCirculation, 2013
- A novel autoantibody recognizing 200‐kd and 100‐kd proteins is associated with an immune‐mediated necrotizing myopathyArthritis & Rheumatism, 2010
- Coenzyme Q10 and Statin Myalgia: What is the Evidence?Current Atherosclerosis Reports, 2010
- Myotoxicity of Lipid-Lowering Agents in a Teenager With MELAS MutationPediatric Neurology, 2008
- Myotonic dystrophy type 2 found in two of sixty‐three persons diagnosed as having fibromyalgiaArthritis & Rheumatism, 2008
- Statins Provoking MELAS SyndromeEuropean Neurology, 2007
- Genetic risk factors associated with lipid‐lowering drug‐induced myopathiesMuscle & Nerve, 2006